MT Pharma America
-
Newly Approved Drug for ALS 'Radicava' Costs Over $145,000 a Year
FDA approves new drug for ALS treatment that costs $145,524 annually.
Latest Research Articles
most popular
-
Colorado Weather Forecast: Snowy Conditions Likely Cause Slushy Roads, Travel Delays This Late Week
-
Midwest, Northeast Weather Forecast: Risk of Damaging Frost Conditions to Bring Cold-Related Health Concerns
-
Climate Change Outpaces Plant Recovery, Turning Forests into Carbon Emitters
-
Mass Bleaching Are Turning Corals 'Ghostly-White' Across 54 Countries
-
China Fur Farm Pose High Risk Of Developing Animal-To-Human Diseases, Study Says
